El tratamiento percutáneo de la enfermedad del tronco coronario continúa siendo uno de los grandes retos de la cardiología intervencionista en el momento actual. La introducción de stents farmacoactivos (SFA) y los Buenos resultados obtenidos en series aisladas han introducido el debate sobre la alternativa de estos stents a la cirugía coronaria en pacientes con enfermedad del tronco coronario no protegido. Aun cuando no se dispone todavía de estudios aleatorizados que avalen la revascularización percutánea con SFA, varios estudios observacionales demuestran que es posible su realización con resultados prometedores a medio y largo plazo. De momento, y a la espera de los resultados de estudios controlados, el cardiólogo intervencionista debe continuar sopesando los riesgos y beneficios de cada caso particular, y probablemente en un futuro próximo podamos por fin modificar las indicaciones de las guías actuales de práctica clínica.
Palabras clave
Stent
Cirugía
Tronco común
Este artículo solo puede leerse en
pdf
Bibliografía
[1.]
P.H. Stone, N. Goldschlager.
Left main coronary artery disease: review and appraisal.
Cardiovasc Med, (1979), 4 pp. 165-177
[2.]
A.R. Gruentzig, A. Sening, W.E. Siegenthaler.
Non operative dilatation of coronary artery: percutaneous transluminal coronary angioplasty.
N Engl J Med, (1979), 301 pp. 61-68
[3.]
J.J. López, K.K. Ho, R.C. Stoler, R.P. Caputo, J.P. Carrozza, R.E. Kuntz, et al.
Percutaneous treatment of protected and unprotected left main coronary stenosis with new devices: inmediate angiographic results and intermediate-term follow-up.
J Am Coll Cardiol, (1997), 29 pp. 345-352
[4.]
J.H. O’Kefee Jr, G.O. Hartzler.
Left main coronary artery angioplasty: early and late results of 127 acute and elective outcomes.
J Am Coll Cardiol, (1989), 64 pp. 144-147
[5.]
E.A. Caracciolo, K.B. Davis, G. Sopko, G.C. Kaiser, S.D. Corley, H. Schaff, et al.
Comparison of surgical and medical group survival in patients with left main coronary artery disease: long-term CASS experience.
Circulation, (1995), 91 pp. 2325-2334
[6.]
T. Takaro, H.N. Hultgren, M.J. Lipton, K.M. Detre.
The VA cooperative randomized study of surgery for coronary arterial occlusive disease. II. Subgroup with significant left main lesions.
Circulation, (1976), 54 pp. III07-III17
[7.]
M. Caputo, B.C. Reeves, C. Rajkaruna, H. Awair, G.D. Angelini.
Incomplete revascularization during OPCAB surgery is associated with reduced mid-term event-free survival.
Ann Thorac Surg, (2005), 80 pp. 2141-2147
[8.]
C.S. McLellan, W.A. Ghali, M. Labinaz, R.B. Davis, P.D. Galbraith, D.A. Southern, et al.
Association between completeness of percutaneous coronary revascularization and postprocedure outcomes.
Am Heart J, (2005), 150 pp. 800-806
[9.]
S.J. Park, S.W. Park, M.K. Hong, C.W. Lee, J.J. Kim, G.S. Mints, et al.
Stenting of unprotected left main coronary artery stenoses: immediate and late outcomes.
J Am Coll Cardiol, (1998), 31 pp. 37-42
[10.]
W.A. Tan, H. Tamai, S.J. Park, H.W. Ploker, M. Nobuyoshi, T. Suzuki, For the ULTIMA Investigators, et al.
Long term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients.
Circulation, (2001), 104 pp. 1609-1614
[11.]
S.J. Park, S.W. Park, M.K. Hong, C.W. Lee, J.H. Lee, J.J. Kim, et al.
Longterm (three-year) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function.
Am J Cardiol, (2003), 91 pp. 12-16
[12.]
S. Silber, P. Albersson, F. Aviles, P. Camici, A. Colombo, C. Hamn, et al.
Guidelines for Percutaneous Coronary Interventions.
Eur Heart J, (2005), 26 pp. 804-847
[13.]
C. Sidney, Smith, T.E. Feldman, J.W. Hirshfeld, A.K. Jacobs, M.J. Kern, et al.
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention.
Circulation, (2006), 136 pp. 156-175
[14.]
S.A.M. Nashef, F. Roque, P. Michel, E. Gauducheau, S. Lemeshow, R. Salamon.
European System for Cardiac Operative Risk Evaluation (EuroSCORE).
Eur Journal of Card-Thor Surgery, (1999), 16 pp. 9-13
[15.]
E. Regar, P.W. Serruys, C. Bode, C. Holubarsch, J.L. Guermonprez, W. Wijns, et al.
Angiographic findings of the multicenter randomized study with the sirolimus-eluting BX velocity balloon-expandable stent (RAVEL).
Circulation, (2002), 106 pp. 1949-1956
[16.]
D.R. Holmes Jr, M.B. Leon, J.W. Moses, J.J. Popma, D. Cutlip, P.J. Fitzgerald, et al.
Analysis of one year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis.
Circulation, (2004), 109 pp. 634-640
[17.]
J. Schofer, M. Schluter, A.H. Gershlick, W. Wijns, E. García, E. Schampaert, et al.
Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).
Lancet, (2003), 362 pp. 1093-1099
[18.]
E. Grube, S. Silver, K.E. Hauptmann, R. Mueller, L. Buellesfeld, U. Gerckens, et al.
TAXUS I: six-and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions.
Circulation, (2003), 107 pp. 38-42
[19.]
A. Gershlick, I.D. Scheerder, B. Chevalier, A. Stephens-Lloyd, E. Camenzind, C. Vrints, et al.
Inhibition of restenosis with a paclitaxeleluting polymer free coronary stent: the European evaluation of paclitaxel-eluting stent (ELUTES) trial.
Circulation, (2004), 109 pp. 487-493
[20.]
G.W. Stone, S.G. Ellis, D.A. Cox, J. Hermiller, C. O'Shaughnessu, J.T. Mann, et al.
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial.
Circulation, (2004), 109 pp. 1942-1947
[21.]
A.J. Lansky, R.A. Costa, G.S. Mintz.
Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial.
Circulation, (2004), 109 pp. 1948-1954
[22.]
R.k. Bottner, L.W. Klein.
Do the current ACC/AHA guidelines correctly reflect the attitudes and utilization of PCI in patients with unprotected left main coronary artery stenosis?.
Cath and Cardiol Interv, (2005), 64 pp. 402-405
[23.]
S.G. Ellis, H. Tamai, M. Nobuyoshi, K. Kosuga, A. Colombo, D.R. Holmes, et al.
Contemporary percutaneous treatment of unprotected left main coronary stenosis.
Circulation, (1997), 96 pp. 3867-3872
[24.]
M.A. Costa, E. Perin, P. Berger, P. Block, S. Katz, S. Ramee.
Initial US experience on treatment of left main disease with sirolimus-eluting stents: insights from the e-Cypher post-marketing surveillance study.
J Am Coll Cardiol, (2005), 45 pp. 54A
[25.]
S. Nakamura, T.S. Muthsamy, J.H. Bae, Y.H. Cahyadi, W. Udayachalerm, D. Damras Tresukosol.
Durable clinical Benedit following sirolimus-eluting stent deployment on the outcome of patients with unprotected left main coronary stenosis: multicenter registry two years results.
J Am Coll Cardiol, (2005), 45 pp. 54A
[26.]
S.J. Park, Y.H. Kim, B.K. Lee, S.W. Lee, C.W. Lee, M.K. Hong, et al.
Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation.
J Am Coll Cardiol, (2005), 45 pp. 351-356
[27.]
L. Lefèvre, M. Silvestre, O. Darremont, S. Hernández, P. Garot, Y. Louvard, et al.
Preliminary results of the Left Main TAXUS Pilot Study.
J Am Coll Cardiol, (2005), 45 pp. 53A
[28.]
García E, Sarnago Cebada F, Cortés M, forns A, Abeytua M, Teijeiro R, et al. Midterm results of unprotected left main coronary artery stenosis treatment in the drug eluting stent era. Presented in the Transcatheter cardiovascular therapeutics (TCT), 2006.
[29.]
M.E. Di Salvo, N. Garro, A. Petralia.
Drug eluting stent in the treatment of unprotected left main disease: immediate results and sixmonths angiographic follow-up.
J Am Coll Cardiol, (2005), 45 pp. 54A
[30.]
A. Chieffo, G. Stankovic, E. Bonizzoni, E. Tsagalou, I. Iakovou, M. Matteo, et al.
Early and mid-term results of drug-eluting stent implantation in unprotected left-main.
Circulation, (2005), 111 pp. 791-795
[31.]
I. Sheiban, C. Moretti, C. Lombardo, M.T. Lucciola, W. Grossomarra, F. Sciuto, et al.
Drug-eluting stents vs bare metal stents in the treatment of unprotected left main coronary artery disease: immediate and long term clinical outcome.
J Am Coll Cardiol, (2005), 45 pp. 54A
[32.]
M. Valgimigli, C.A. Van Mieghem, A.T. Ong, J. Aoki, G.A. Granillo, E.P. Mc Fadden, et al.
Short and long-term outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamicin-eluting and Taxus Stent Evaluated at Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH).
Circulation, (2005), 111 pp. 1383-1389
[33.]
A. Chieffo, N. Morici, F. Maisano, E. Bonizzoni, J. Cosgrave, M. Montorfano.
Percutaneous treatment with DES implantation vs By-pass surgery for unprotected left main stenosis: a single center experience.
Circulation, (2006), 113 pp. 2542-2547
[34.]
M.S. Lee, N. Kapoor, F. Jarnal, L. Czer, J. Aragon, J. Forrester, et al.
Comparison of coronary artery bypass surgery with coronary percutaneous intervention with drug-eluting stents for unprotected left main coronary artery disease.
J Am Coll Cardiol, (2006), 47 pp. 864-869
[35.]
I. Iakovou, L. Ge, A. Colombo.
Contemporary stent treatment of coronary bifurcations.
J Am Coll Cardiol, (2005), 46 pp. 1446-1455
[36.]
I. Iakobou, T. Schmidt, E. Bonizzoni, L. Gel, G.M. Sangiorgi, G. Stankovic, et al.
Incidence, predictors and outcome of trombosis after successful implantation of drug-eluting stents.
JAMA, (2005), 293 pp. 2126-2130
[37.]
P.K. Kucholakanti, W.W. Chu, R. Torguson, P. Ohlmann, S.W. Rha, L.C. Clavijo, et al.
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus-and paclitaxel-eluting stents.
Circulation, (2006), 113 pp. 1108-1134
[38.]
M. Valmigli, P. Malagutti, G. Rodríguez-Granillo, H.M. García-García, J. Polad, K. Tsuchida, et al.
Distal left main coronary disease is a major predictive of outcome in patients undergoing percutaneous intervention in the drug-eluting stens era.
J Am Coll Cardiol, (2006), 47 pp. 1530-1537
[39.]
Y.J. Kim, S.W. Park, M.K. Hong, D.W. Park, K.M. Park, B.K. Lee, et al.
Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis.
Am J Cardiol, (2006), 97 pp. 1597-1601
[40.]
S.J. Park, M.K. Hong, C.W. Lee, J.J. kim, J.K. Song, D.H. Kang, et al.
Elective stenting of unprotected left main coronary artery stenosis: effect of debulking before stenting and intravascular ultrasound guidance.
J Am Coll Cardiol, (2001), 38 pp. 1054-1060
[41.]
M.J. Price, E. Cristea, N. Sawhney, J.A. Kao, J.W. Moses, M.B. Leon, et al.
Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularizatio.
J Am Coll Cardiol, (2006), 47 pp. 871-877
Copyright ©
2007. Sociedad Española de Cardiología